Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

Support for adults with food and non-food allergy 10th July 2026

Food and non-food allergies are often associated with childhood, but millions of adults across the UK live with allergies too. Around 6% of the UK adult population has a clinically confirmed food allergy, equating to approximately 2.4 million people[1]. Many
[…]

Read more
Lower dose EURneffy® nasal adrenaline spray approved by MHRA for younger children 30th June 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four years and over. This adrenaline device option is
[…]

Read more
Anaphylaxis UK welcomes launch of Natasha’s Prize 22nd June 2026

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting people living with serious allergies, Anaphylaxis UK warmly
[…]

Read more

News Type:

Charity concert returns in honour of schoolboy who lost his life to allergic reaction 28th March 2023

‘The Hope Hoot’, returning for its second year following a three-year hiatus, will be raising money and awareness for two allergy charities, Allergy UK and Anaphylaxis UK.

Read more
Introduction of peanuts at four to six months can reduce risk of allergy, new analysis suggests  20th March 2023

A new analysis that looked at the optimal timing of introducing peanut products to babies to prevent peanut allergy suggests that a 77% reduction in peanut allergy could be achieved if peanut was introduced to all babies at four to six months of age. 

Read more
MHRA issues recall on pholcodine-containing medicines 15th March 2023

Following a scientific review of the safety of pholcodine, the Medicines and Healthcare products Regulatory Agency (MHRA), with advice from the independent Commission on Human Medicines, has recommended that all pholcodine-containing cough and cold medicines should be withdrawn as a precautionary measure. 

Read more
Precautionary Allergen Labelling (PAL): What lies ahead (online webinar) 13th March 2023

The Affidia Journal will be hosting an online webinar entitled Precautionary Allergen Labelling (PAL): What lies ahead on 23 March, 3 – 5pm.

Read more
Allergy-safe Easter activities 12th March 2023

For many people, Easter is the time of year for indulging in chocolate and all kinds of other sweet treats.

Read more
New and improved AllergyWise® for Schools course for all school staff 8th March 2023

We are moving our AllergyWise® courses to our new learning platform on the Anaphylaxis UK website. The new platform provides a smoother training experience and features our updated and improved AllergyWise® for Schools course. 

Read more
Healthcare professionals urged to check for food allergens in medication  8th March 2023

Anaphylaxis UK is urging healthcare professionals to make sure that medication prescribed to their patients does not contain ingredients that they are allergic too.  

Read more
Living with a Latex Allergy- latest YouTube video 2nd March 2023

Jo talks about her struggles with avoiding contact with latex gloves and rubber while on duty and how this impacted her ability to do her job. She shares how she developed the allergy in her late 20s, despite having no prior history of a serious allergy.

Read more
New data shows COVID vaccines rate of anaphylaxis same as other vaccines  1st March 2023

A review of recent data regarding frequency of allergic reactions has shown similar rates of anaphylaxis to COVID vaccines as to other vaccines.  

Read more